Taysha Gene Therapies, Inc. Quarterly Other Assets, Current in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Taysha Gene Therapies, Inc. quarterly Other Assets, Current history and growth rate from Q4 2020 to Q3 2024.
  • Taysha Gene Therapies, Inc. Other Assets, Current for the quarter ending September 30, 2024 was $465K, a 15.1% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $465K +$61K +15.1% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $206K -$304K -59.6% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $149K -$383K -72% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $292K -$174K -37.3% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $404K +$24K +6.32% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $510K -$167K -24.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $532K -$409K -43.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $466K -$397K -46% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $380K -$782K -67.3% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $677K -$337K -33.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $941K +$102K +12.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $863K +$532K +161% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $1.16M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.01M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $839K Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $331K Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.